matrix metalloproteinase inhibitors (Forge/Janssen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namematrix metalloproteinase inhibitors (Forge/Janssen)
Drug Alias Namematrix metalloproteinase inhibitors (University of California San Diego)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsHeart DiseasesArthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaBlacksmith Medicines IncUniversity Of California San Diego +[4] 
Active IndicationsN/A
Inactive IndicationsHeart DiseasesArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A